Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: AzurRx BioPharma Will Conduct Phase 2b Trial of MS1819 at TDN Clinical Sites Stop Making Yourself Sick About Other Sick People COVID-19 Outcomes in CF Patients Similar to General Public, Study Suggests AzurRx BioPharma Will Conduct Phase 2b Trial of MS1819 at TDN Clinical Sites May 06, 2020 07:00 am | Joana Carvalho, PhD AzurRx BioPharma has been authorized to conduct its Phase 2b OPTION 2 clinical trial evaluating MS1819, its investigative therapy for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF), at sites that are part of the Therapeutics Development Network (TDN). TDN is the largest network of CF clinical trials in the world. Supported by the Cystic […] The post AzurRx BioPharma Will Conduct Phase 2b Trial of MS1819 at TDN Clinical Sites appeared first on Cystic Fibrosis News Today. Read More Stop Making Yourself Sick About Other Sick People May 05, 2020 03:00 pm | Bailey Vincent I have written about many subjects, but I’ll never stop writing about one: Why are we hateful of someone else’s body? The internet is full of trolls. We shouldn’t give them more credence than we already have, but the worst kind of troll is a chronically sick one who believes they’re just “trying to understand” […] The post Stop Making Yourself Sick About Other Sick People appeared first on Cystic Fibrosis News Today. Read More COVID-19 Outcomes in CF Patients Similar to General Public, Study Suggests May 05, 2020 07:00 am | Ines Martins, PhD People with cystic fibrosis (CF) infected with the new coronavirus appear to have better outcomes than initially anticipated, with their COVID-19 disease following a course similar to that of the general population, an international study suggests. This research also points to a lower incidence of coronavirus infections in this patient group compared to the public-at-large, […] The post COVID-19 Outcomes in CF Patients Similar to General Public, Study Suggests appeared first on Cystic Fibrosis News Today. Read More   Recent News CHMP Favors Expanding Kalydeco Label to Include Young Children With R117H Mutation NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts The Counseling Connection Vertex Joins with Affinia Therapeutics to Develop Gene Therapies for CF Orkambi Helps to Promote Glucose Tolerance in CF Patients, Study Finds